Molecular mechanisms of gene silencing by H4 methylation

H4甲基化基因沉默的分子机制

基本信息

  • 批准号:
    7894449
  • 负责人:
  • 金额:
    $ 30.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-01 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The histone proteins are responsible for the compaction and functional organization of DMA in the nucleus. These small, evolutionary conserved proteins are host to a diverse array of post-translational modifications, each of which is typically associated with a specific DNA-templated process, such as gene regulation. We recently discovered a novel mammalian gene silencing pathway mediated by the PR-Set7 enzyme that specifically monomethylates histone H4 lysine 20 (H4K20). Our new findings indicate that this silencing pathway is targeted to the promoters of certain genes that function in growth and differentiation programs. Based on these findings, our central hypothesis is that one major role of H4K20 monomethylation is to maintain cellular identity by repressing specific sets of genes that promote growth and differentiation. The goal of this proposal is to dissect the molecular mechanisms of this fundamental gene silencing pathway with the long range goal of determining the role of this pathway in establishing and maintaining cellular identity. We recently discovered that PR-Set7 associates with a novel histone H3 lysine 9 (H3K9) methyltransferase to create a repressive monomethyl-H4K20 and H3K9 "trans-tail histone code" at gene promoters. In Aim 1 we will use established molecular and biochemical methods to identify and characterize this enzyme and determine its in vivo role in gene repression. We have also discovered the first known H4K20 monomethyl- binding protein, L(3)MBT, and determined that this interaction is essential for gene repression. In Aim 2 we will define the regions and amino acids of L(3)MBT required for binding monomethylated H4K20 and gene repression. In Aim 3 we will continue to identify additional genes regulated by this silencing pathway. These genes serve as the in vivo models to dissect apart the individual contributions of each of the components of this pathway on in vivo gene repression. Collectively, this proposal will illuminate the molecular mechanisms of a fundamental mammalian gene regulation pathway involved in critical biological processes and will likely have far-reaching and wide-spread impacts on human health and disease.
描述(由申请人提供):组蛋白负责细胞核中DMA的压实和功能组织。这些小的、进化上保守的蛋白质是多种翻译后修饰的宿主,每种修饰通常与特定的DNA模板化过程(例如基因调控)相关。我们最近发现了一种新的哺乳动物基因沉默途径介导的PR-Set 7酶,特异性单甲基化组蛋白H4赖氨酸20(H4 K20)。我们的新发现表明,这种沉默途径是针对某些基因的启动子,这些基因在生长和分化程序中发挥作用。基于这些发现,我们的中心假设是H4 K20单甲基化的一个主要作用是通过抑制促进生长和分化的特定基因组来维持细胞身份。本提案的目标是剖析这一基本基因沉默途径的分子机制,其长期目标是确定这一途径在建立和维持细胞身份中的作用。我们最近发现,PR-Set 7与一种新的组蛋白H3赖氨酸9(H3 K9)甲基转移酶相关联,在基因启动子处产生抑制性单甲基-H4 K20和H3 K9“反尾组蛋白密码”。在目标1中,我们将使用已建立的分子和生物化学方法来鉴定和表征这种酶,并确定其在基因阻遏中的体内作用。我们还发现了第一个已知的H4 K20单甲基结合蛋白,L(3)MBT,并确定这种相互作用是基因抑制所必需的。在目标2中,我们将定义L(3)MBT结合单甲基化H4 K20和基因阻遏所需的区域和氨基酸。在目标3中,我们将继续鉴定由这种沉默途径调节的其他基因。这些基因作为体内模型来剖析该途径的每个组分对体内基因抑制的单独贡献。总的来说,这一提议将阐明关键生物过程中涉及的基本哺乳动物基因调控途径的分子机制,并可能对人类健康和疾病产生深远和广泛的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JUDD C RICE其他文献

JUDD C RICE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JUDD C RICE', 18)}}的其他基金

Advancing an Innovative NGS Approach to Discover and Investigate Histone Tail Proteolysis
推进创新的 NGS 方法来发现和研究组蛋白尾部蛋白水解
  • 批准号:
    10575717
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
Molecular mechanisms of gene silencing by H4 methylation
H4甲基化基因沉默的分子机制
  • 批准号:
    7313347
  • 财政年份:
    2007
  • 资助金额:
    $ 30.47万
  • 项目类别:
Molecular mechanisms of gene silencing by H4 methylation
H4甲基化基因沉默的分子机制
  • 批准号:
    7477738
  • 财政年份:
    2007
  • 资助金额:
    $ 30.47万
  • 项目类别:
Molecular mechanisms of gene silencing by H4 methylation
H4甲基化基因沉默的分子机制
  • 批准号:
    8101342
  • 财政年份:
    2007
  • 资助金额:
    $ 30.47万
  • 项目类别:
Molecular mechanisms of gene silencing by H4 methylation
H4甲基化基因沉默的分子机制
  • 批准号:
    7661426
  • 财政年份:
    2007
  • 资助金额:
    $ 30.47万
  • 项目类别:
Epigenetic silencing by histone methylation
组蛋白甲基化导致的表观遗传沉默
  • 批准号:
    6636706
  • 财政年份:
    2001
  • 资助金额:
    $ 30.47万
  • 项目类别:
Epigenetic silencing by histone methylation
组蛋白甲基化导致的表观遗传沉默
  • 批准号:
    6405124
  • 财政年份:
    2001
  • 资助金额:
    $ 30.47万
  • 项目类别:
Epigenetic silencing by histone methylation
组蛋白甲基化导致的表观遗传沉默
  • 批准号:
    6520587
  • 财政年份:
    2001
  • 资助金额:
    $ 30.47万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
    Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
  • 批准号:
    23H02155
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
  • 批准号:
    10788032
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
  • 批准号:
    23K14742
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
  • 批准号:
    10864719
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
  • 批准号:
    10586562
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
  • 批准号:
    10593224
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
  • 批准号:
    23K06589
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
  • 批准号:
    10623380
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
  • 批准号:
    10735148
  • 财政年份:
    2023
  • 资助金额:
    $ 30.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了